Author

Marie Liebmann

University Hospital MünsterORCID 0000-0002-5565-5325Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Neuroscience· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Organism:human· 1

Frequent Co-Authors

Antje Schmidt‐PogodaiD· 2 shared Carolin BeukeriD· 2 shared Christian ThomasiD· 2 shared Jan‐Kolja StreckeriD· 2 shared Jens MinnerupiD· 2 shared Johannes RothiD· 2 shared Julian Revenstorff· 2 shared Luisa KlotziD· 2 shared

Activity by Year

2022-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersNeuroscience

Antje Schmidt‐PogodaORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

The nuclear receptor NR4A1 serves as a neutrophil-intrinsic regulator mitigating stroke severity

Jan‐Kolja Strecker, Yannick Schmidt, Marie Liebmann, Carolin Walter, Stefan Roth, Hanna Aleth, Anna-Lena Börsch, Antje Schmidt‐Pogoda, Carolin Beuker, Ayan Mohamud Yusuf, Julian Revenstorff, Collins Osei-Sarpong, Lisa Krafft, Anna-Sophie Schwarze, Michael Heming, , Jens Minnerup

This study identifies NR4A1 as a neutrophil-intrinsic regulator that reduces stroke severity by limiting inflammation and brain damage through pharmacological modulation.

bioRxiv · Sep 19, 2025 · PreprintNeuroscience

The nuclear receptor NR4A1 restrains neutrophil granulocyte mediated brain damage in cerebral ischemia

Jan‐Kolja Strecker, Marie Liebmann, Julian Revenstorff, Carolin Beuker, Antje Schmidt‐Pogoda, Stephanie Hucke, Thomas Vogl, Johannes Roth, Christian Thomas, Tanja Kuhlmann, Heinz Wiendl, Luisa Klotz, Jens Minnerup

This study shows NR4A1 reduces brain damage after ischemic stroke by limiting neutrophil activation and recruitment, with Cytosporone-B improving outcomes.

bioRxiv · Feb 27, 2022 · PreprintNeuroscience